BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 26866675)

  • 1. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
    Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
    Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
    Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
    J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of
    Nakashima K; Iikuni S; Okada Y; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
    Nucl Med Biol; 2021 Feb; 93():46-53. PubMed ID: 33316738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of
    Zhang Z; Lau J; Zhang C; Colpo N; Nocentini A; Supuran CT; Bénard F; Lin KS
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):722-730. PubMed ID: 28385087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of indium-111-labeled imidazothiadiazole sulfonamide derivative for single photon emission computed tomography imaging targeting carbonic anhydrase-IX.
    Iikuni S; Okada Y; Shimizu Y; Watanabe H; Ono M
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127255. PubMed ID: 32527556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography.
    Pan J; Lau J; Mesak F; Hundal N; Pourghiasian M; Liu Z; Bénard F; Dedhar S; Supuran CT; Lin KS
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):249-55. PubMed ID: 23463940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in Vivo Biological Evaluation of (68)Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography.
    Sneddon D; Niemans R; Bauwens M; Yaromina A; van Kuijk SJ; Lieuwes NG; Biemans R; Pooters I; Pellegrini PA; Lengkeek NA; Greguric I; Tonissen KF; Supuran CT; Lambin P; Dubois L; Poulsen SA
    J Med Chem; 2016 Jul; 59(13):6431-43. PubMed ID: 27322137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography.
    Lau J; Pan J; Zhang Z; Hundal-Jabal N; Liu Z; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3064-8. PubMed ID: 24878197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the
    Iikuni S; Tanimura K; Watanabe H; Shimizu Y; Saji H; Ono M
    Mol Pharm; 2019 Apr; 16(4):1489-1497. PubMed ID: 30892905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide.
    Iikuni S; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
    PLoS One; 2020; 15(12):e0243327. PubMed ID: 33296398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of
    Nakai M; Pan J; Lin KS; Thompson JR; Nocentini A; Supuran CT; Nakabayashi Y; Storr T
    J Inorg Biochem; 2018 Aug; 185():63-70. PubMed ID: 29778927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetazolamide-based [
    More KN; Lee JY; Kim DY; Cho NC; Pyo A; Yun M; Kim HS; Kim H; Ko K; Park JH; Chang DJ
    Bioorg Med Chem Lett; 2018 Mar; 28(5):915-921. PubMed ID: 29422388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
    Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
    Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia.
    Akurathi V; Dubois L; Lieuwes NG; Chitneni SK; Cleynhens BJ; Vullo D; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
    Nucl Med Biol; 2010 Jul; 37(5):557-64. PubMed ID: 20610160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer radiotheranostics targeting carbonic anhydrase-IX with
    Iikuni S; Ono M; Watanabe H; Shimizu Y; Sano K; Saji H
    Theranostics; 2018; 8(11):2992-3006. PubMed ID: 29896298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and biological evaluation of ⁹⁹mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers.
    Akurathi V; Dubois L; Celen S; Lieuwes NG; Chitneni SK; Cleynhens BJ; Innocenti A; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
    Eur J Med Chem; 2014 Jan; 71():374-84. PubMed ID: 24378650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties.
    Iikuni S; Okada Y; Shimizu Y; Watanabe H; Ono M
    Mol Pharm; 2021 Mar; 18(3):966-975. PubMed ID: 33472371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Linker Modification on Tumor-to-Kidney Contrast of
    Kuo HT; Pan J; Zhang Z; Lau J; Merkens H; Zhang C; Colpo N; Lin KS; Bénard F
    Mol Pharm; 2018 Aug; 15(8):3502-3511. PubMed ID: 29920108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.